Biosynex: acquires Innoxa's eye care business
Biosynex underlines that this market is accelerating, particularly with the ageing of the population (increased fragility of the eyes and dry eyes) and the growing exposure of the population to screens (computers and cell phones).
The scope includes a complete range of eye care products (sprays, eye drops, etc.) to treat irritated, red or tired eyes, as well as cleaning products for contact lenses and eyeglasses.
Biosynex plans to roll out these new ranges of eye care products through its extensive network of pharmacies in France, and through its subsidiaries throughout the European market.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction